318
Views
52
CrossRef citations to date
0
Altmetric
Commentary

Increasing importance of dry eye syndrome and the ideal artificial tear: consensus views from a roundtable discussion

Pages 2149-2157 | Accepted 21 Aug 2006, Published online: 28 Sep 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (9)

Alejandro Rodriguez-Garcia, Alejandro Babayan-Sosa, Arturo Ramirez-Miranda, Concepcion Santa Cruz-Valdes, Everardo Hernandez-Quintela, Julio C Hernandez-Camarena, Nallely Ramos-Betancourt, Regina Velasco-Ramos & Raul E Ruiz-Lozano. (2022) A Practical Approach to Severity Classification and Treatment of Dry Eye Disease: A Proposal from the Mexican Dry Eye Disease Expert Panel. Clinical Ophthalmology 16, pages 1331-1355.
Read now
Michele Figus, Luca Agnifili, Manuela Lanzini, Lorenza Brescia, Francesco Sartini, Leonardo Mastropasqua & Chiara Posarelli. (2021) Topical preservative-free ophthalmic treatments: an unmet clinical need. Expert Opinion on Drug Delivery 18:6, pages 655-672.
Read now
Karen Walsh & Lyndon Jones. (2019) The use of preservatives in dry eye drops. Clinical Ophthalmology 13, pages 1409-1425.
Read now
Nariman Nassiri, Yasaira Rodriguez Torres, Zachary Meyer, Michael A. Beyer, Gautham Vellaichamy, Amar S. Dhaliwal, Neil Chungfat & Frank S. Hwang. (2017) Current and emerging therapy of dry eye disease. Part A: pharmacological modalities. Expert Review of Ophthalmology 12:4, pages 269-297.
Read now
Majid Moshirfar, Kasey Pierson, Kamalani Hanamaikai, Luis Santiago-Caban, Valliammai Muthappan & Samuel F Passi. (2014) Artificial tears potpourri: a literature review. Clinical Ophthalmology 8, pages 1419-1433.
Read now
Piera Versura, Vincenzo Profazio, Nicole Balducci & Emilio C Campos. (2010) Efficacy of two-month treatment with Xiloial® eyedrops for discomfort from disposable soft contact lenses. Clinical Ophthalmology 4, pages 1035-1041.
Read now

Articles from other publishers (43)

Maitri Bhatt & Pravin Shende. (2023) Nano-dimensional in-situ hydrogels of lifitegrast: An advancement in preservation time, sustained release and corneal healing in dry eye syndrome. Journal of Drug Delivery Science and Technology 89, pages 105018.
Crossref
Youngsub Eom, So Hyang Chung, Tae-Young Chung, Jae Yong Kim, Chul Young Choi, Kyung Chul Yoon, Byung Yi Ko, Hong Kyun Kim, Mee Kum Kim, Hyung Keun Lee, Jong Suk Song, Joon Young Hyon, Kyoung Yul Seo, Jong Soo Lee & Hyo Myung Kim. (2023) Efficacy and safety of 1% and 2% rebamipide clear solution in dry eye disease: a multicenter randomized trial. BMC Ophthalmology 23:1.
Crossref
Ali Abusharha, Ian E. Pearce, Tayyaba Afsar & Suhail Razak. (2023) Evaluation of Therapeutic Capability of Emustil Drops against Tear Film Complications under Dry Environmental Conditions in Healthy Individuals. Medicina 59:7, pages 1298.
Crossref
Vineet Pramod Joshi, Swati Singh, Minal Thacker, Falguni Pati, Geeta K Vemuganti, Sayan Basu & Vivek Singh. (2023) Newer approaches to dry eye therapy: Nanotechnology, regenerative medicine, and tissue engineering. Indian Journal of Ophthalmology 71:4, pages 1292-1303.
Crossref
Minal Thacker, Vivek Singh, Sayan Basu & Swati Singh. (2023) Biomaterials for dry eye disease treatment: Current overview and future perspectives. Experimental Eye Research 226, pages 109339.
Crossref
Yi-Chen Sun, Li-Li Wu, Yu-An Chang, Tzu-Yun Li, Yang Lin, Fung-Rong Hu, Wei-Bor Tsai & Kai-Feng Hung. (2022) Zwitterionic poly(carboxybetaine methacrylate) (polyCBMA) decreases desiccating damage to corneal epithelial cells. Colloid and Interface Science Communications 50, pages 100648.
Crossref
Jeremy Nortey, David Smith, Gerami D. Seitzman & John A. Gonzales. (2022) Topical Therapeutic Options in Corneal Neuropathic Pain. Frontiers in Pharmacology 12.
Crossref
Anna Hovakimyan. 2022. Medical Atlas of Cornea and External Diseases in Middle Eastern Populations. Medical Atlas of Cornea and External Diseases in Middle Eastern Populations 34 47 .
Minji Kim, Yonghoon Lee, Divy Mehra, Alfonso L Sabater & Anat Galor. (2021) Dry eye: why artificial tears are not always the answer. BMJ Open Ophthalmology 6:1, pages e000697.
Crossref
B.N. Kumara, Rashmi Shambhu & K. Sudhakara Prasad. (2021) Why chitosan could be apt candidate for glaucoma drug delivery - An overview. International Journal of Biological Macromolecules 176, pages 47-65.
Crossref
Mohammed A. Aljarousha, Noor E. Badarudin, Mohd Z. Che Azemin, Yousef Aljeesh & Amer Abuimara. (2021) A systematic review on prevalence, risk factors, clinical diagnosis and medical management of dry eye disease in the Arab population. African Vision and Eye Health 80:1.
Crossref
AdetunjiOlusesan Adenekan, OlubankeTheodora Ilo, AdegboyegaSunday Alabi, OlufisayoTemitayo Aribaba & FolasadeBolanle Akinsola. (2021) Prevalence and pattern of dry eye symptoms among “okada” riders in Southwest Nigeria using the ocular surface disease index: A cross sectional study. Journal of Clinical Sciences 18:2, pages 81.
Crossref
Johannes Nepp, Wolfgang Knoetzl, Anna Prinz, Sonja Hoeller & Martin Prinz. (2020) Management of moderate-to-severe dry eye disease using chitosan-N-acetylcysteine (Lacrimera®) eye drops: a retrospective case series. International Ophthalmology 40:6, pages 1547-1552.
Crossref
Sharon D'Souza, Edwin James, Rishi Swarup, Sheetal Mahuvakar, Aditya Pradhan & Krati Gupta. (2020) Algorithmic approach to diagnosis and management of post-refractive surgery dry eye disease. Indian Journal of Ophthalmology 68:12, pages 2888.
Crossref
Ali M. Masmali. (2019) Improvement of ferning patterns of lubricant eye drops mixed with various electrolytes and carboxymethylcellulose. Contact Lens and Anterior Eye 42:6, pages 633-639.
Crossref
Marco Messina & Harminder S. Dua. (2018) Early results on the use of chitosan-N-acetylcysteine (Lacrimera®) in the management of dry eye disease of varied etiology. International Ophthalmology 39:3, pages 693-696.
Crossref
Stephan SzegediUlrike ScheschyDoreen SchmidlValentin Aranha dos SantosHannes StegmannNarine AdzhemianKlemens FondiAhmed M. BataRené M. WerkmeisterChantal CoudercLeopold SchmettererGerhard Garhofer. (2018) Effect of Single Instillation of Two Hyaluronic Acid-Based Topical Lubricants on Tear Film Thickness in Patients with Dry Eye Syndrome. Journal of Ocular Pharmacology and Therapeutics 34:9, pages 605-611.
Crossref
Michael Samsom, Myrto Korogiannaki, Lakshman N. Subbaraman, Heather Sheardown & Tannin A. Schmidt. (2017) Hyaluronan incorporation into model contact lens hydrogels as a built‐in lubricant: Effect of hydrogel composition and proteoglycan 4 as a lubricant in solution. Journal of Biomedical Materials Research Part B: Applied Biomaterials 106:5, pages 1818-1826.
Crossref
Maurizio Rolando, Emilia Cantera, Rita Mencucci, Pierangela Rubino & Pasquale Aragona. (2017) The correct diagnosis and therapeutic management of tear dysfunction: recommendations of the P.I.C.A.S.S.O. board. International Ophthalmology 38:2, pages 875-895.
Crossref
Eun Chul Kim. (2018) Diagnosis and treatment of dry eye syndrome. Journal of the Korean Medical Association 61:6, pages 352.
Crossref
Etty Bitton, Carolyn Perugino & Stéphanie Charette. (2017) Comparison of Ocular Lubricant Osmolalities. Optometry and Vision Science 94:6, pages 694-699.
Crossref
Alexandra Partenhauser & Andreas Bernkop-Schnürch. (2016) Mucoadhesive polymers in the treatment of dry X syndrome. Drug Discovery Today 21:7, pages 1051-1062.
Crossref
Laura E. Downie, Nicholas Rumney, Anne Gad, Peter R. Keller, Christine Purslow & Algis J. Vingrys. (2016) Comparing self-reported optometric dry eye clinical practices in Australia and the United Kingdom: is there scope for practice improvement?. Ophthalmic and Physiological Optics 36:2, pages 140-151.
Crossref
J.A.H. Eekhof, A. Knuistingh Neven & W. OpsteltenY.D. van Leeuwen & J.L. Baggen. 2016. Kleine kwalen in de huisartsenpraktijk. Kleine kwalen in de huisartsenpraktijk 422 424 .
Just Eekhof, Arie Knuistingh Neven, Sjoerd Bruggink & Marissa Scherptong-EngbersYvonne van Leeuwen & Carla Stuurman. 2016. Kleine kwalen en alledaagse klachten bij ouderen. Kleine kwalen en alledaagse klachten bij ouderen 199 202 .
Coziana Ciurtin, Anca Ostas, Viorica M. Cojocaru, Stephen B. Walsh & David A. Isenberg. (2015) Advances in the treatment of ocular dryness associated with Sjögren׳s syndrome. Seminars in Arthritis and Rheumatism 45:3, pages 321-327.
Crossref
Laura E. Downie & Peter R. Keller. (2015) A Pragmatic Approach to the Management of Dry Eye Disease. Optometry and Vision Science 92:9, pages 957-966.
Crossref
Seray Aslan Bayhan, Hasan Ali Bayhan, Ersin Muhafız, Şükran Bekdemir & Canan Gürdal. (2015) Effects of osmoprotective eye drops on tear osmolarity in contact lens wearers. Canadian Journal of Ophthalmology 50:4, pages 283-289.
Crossref
Ayse Yagci & Canan Gurdal. (2014) The role and treatment of inflammation in dry eye disease. International Ophthalmology 34:6, pages 1291-1301.
Crossref
Michael L. Samsom, Sheila Morrison, Nemanja Masala, Benjamin D. Sullivan, David A. Sullivan, Heather Sheardown & Tannin A. Schmidt. (2014) Characterization of full-length recombinant human Proteoglycan 4 as an ocular surface boundary lubricant. Experimental Eye Research 127, pages 14-19.
Crossref
Kati Kinnunen, Anu Kauppinen, Niina Piippo, Arto Koistinen, Elisa Toropainen & Kai Kaarniranta. (2014) Cationorm shows good tolerability on human HCE-2 corneal epithelial cell cultures. Experimental Eye Research 120, pages 82-89.
Crossref
Se Ran JangIl Suk YunHun Sub LimKoung Hoon Kook. (2014) Comparison of Wettability for Ocular Prosthesis Depending on Different Kinds of Artificial Tear Eye Drops. Journal of the Korean Ophthalmological Society 55:12, pages 1745.
Crossref
Wing Y. Li, Carol Hsiao, Andrew D. Graham & Meng C. Lin. (2013) Corneal epithelial permeability: Ethnic differences between Asians and non-Asians. Contact Lens and Anterior Eye 36:5, pages 215-218.
Crossref
Shigeru Kinoshita, Kazuhide Oshiden, Saki Awamura, Hiroyuki Suzuki, Norihiro Nakamichi & Norihiko Yokoi. (2013) A Randomized, Multicenter Phase 3 Study Comparing 2% Rebamipide (OPC-12759) with 0.1% Sodium Hyaluronate in the Treatment of Dry Eye. Ophthalmology 120:6, pages 1158-1165.
Crossref
João M. Beirão, Maria E. Matos, Idalina B. Beirão, Paulo P. Costa & Paulo A. Torres. (2012) Topical Cyclosporine for Severe Dry Eye Disease in Liver-Transplanted Portuguese Patients with Familial Amyloidotic Polyneuropathy (ATTRV30M). European Journal of Ophthalmology 23:2, pages 156-163.
Crossref
Natália R. Pires, Pablyana L.R. Cunha, Jeanny S. Maciel, Alysson L. Angelim, Vania M.M. Melo, Regina C.M. de Paula & Judith P.A. Feitosa. (2013) Sulfated chitosan as tear substitute with no antimicrobial activity. Carbohydrate Polymers 91:1, pages 92-99.
Crossref
Louis Tong, Andrea Petznick, SzeYee Lee & Jeremy Tan. (2012) Choice of Artificial Tear Formulation for Patients With Dry Eye. Cornea 31:Supplement 1, pages S32-S36.
Crossref
Louis Tong, Andrea Petznick, Sze Yee Lee & Jeremy Tan. (2012) Assessment and Management of Dry Eye Patients for Non-Ophthalmic Healthcare Practitioners. Proceedings of Singapore Healthcare 21:1, pages 15-22.
Crossref
Sheila Morrison, David A Sullivan, Benjamin D Sullivan, Heather Sheardown & Tannin A Schmidt. (2012) Dose-Dependent and Synergistic Effects of Proteoglycan 4 on Boundary Lubrication at a Human Cornea–Polydimethylsiloxane Biointerface. Eye & Contact Lens: Science & Clinical Practice 38:1, pages 27-35.
Crossref
Camus Kar Man Choy, Pauline Cho & Iris F. F. Benzie. (2011) Antioxidant Content and Ultraviolet Absorption Characteristics of Human Tears. Optometry and Vision Science 88:4, pages 507-511.
Crossref
Nariman Nassiri, Ali R. Djalilian, Pedram Hamrah & Stephen C. Pflugfelder. 2011. Cornea. Cornea 425 443 .
Hannu Uusitalo, Kai Kaarniranta & Auli Ropo. (2008) Pharmacokinetics, efficacy and safety profiles of preserved and preservative‐free tafluprost in healthy volunteers. Acta Ophthalmologica 86:s242, pages 7-13.
Crossref
F. Fajnkuchen, V. Sarda & G. Chaine. (2008) Œil sec. EMC - Ophtalmologie 5:1, pages 1-13.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.